Westergaard, David https://orcid.org/0000-0003-0128-8432
Steinthorsdottir, Valgerdur https://orcid.org/0000-0003-1846-6274
Stefansdottir, Lilja
Rohde, Palle Duun https://orcid.org/0000-0003-4347-8656
Wu, Xiaoping https://orcid.org/0000-0002-7844-1397
Geller, Frank https://orcid.org/0000-0002-9238-3269
Tyrmi, Jaakko
Havulinna, Aki S.
Solé-Navais, Pol https://orcid.org/0000-0002-3326-266X
Flatley, Christopher https://orcid.org/0000-0002-2225-0188
Ostrowski, Sisse Rye https://orcid.org/0000-0001-5288-3851
Pedersen, Ole Birger https://orcid.org/0000-0003-2312-5976
Erikstrup, Christian https://orcid.org/0000-0001-6551-6647
Sørensen, Erik
Mikkelsen, Christina https://orcid.org/0000-0002-2945-6197
Bruun, Mie Topholm https://orcid.org/0000-0002-8819-5388
Aagaard Jensen, Bitten
Brodersen, Thorsten https://orcid.org/0000-0003-4431-9972
Ullum, Henrik
,
,
,
,
Magnus, Per https://orcid.org/0000-0002-6427-4735
Andreassen, Ole A. https://orcid.org/0000-0002-4461-3568
Njolstad, Pål R. https://orcid.org/0000-0003-0304-6728
Kolte, Astrid Marie
Krebs, Lone https://orcid.org/0000-0001-5433-4776
Nyegaard, Mette https://orcid.org/0000-0003-4973-8543
Hansen, Thomas Folkmann https://orcid.org/0000-0001-6703-7762
Feenstra, Bjarke https://orcid.org/0000-0003-1478-649X
Daly, Mark
Lindgren, Cecilia M.
Thorleifsson, Gudmar https://orcid.org/0000-0003-4623-9087
Stefansson, Olafur A. https://orcid.org/0000-0002-9663-3018
Sveinbjornsson, Gardar https://orcid.org/0000-0003-2429-9468
Gudbjartsson, Daniel F. https://orcid.org/0000-0002-5222-9857
Thorsteinsdottir, Unnur
Banasik, Karina
Jacobsson, Bo https://orcid.org/0000-0001-5079-2374
Laisk, Triin https://orcid.org/0000-0003-1501-9030
Laivuori, Hannele https://orcid.org/0000-0003-3212-7826
Stefansson, Kari
Brunak, Søren https://orcid.org/0000-0003-0316-5866
Nielsen, Henriette Svarre https://orcid.org/0000-0003-2106-8103
Article History
Received: 24 August 2023
Accepted: 21 June 2024
First Online: 22 July 2024
Competing interests
: H.S.N. obtained speaker fees from Ferring Pharmaceuticals, Merck, AstraZeneca, Novo Nordisk and Cook Medical. S.B. has obtained speaker fees from MDS, Bayer, LEO Pharma and Astellas and has ownership in Hoba Therapeutics, Novo Nordisk, Lundbeck, ALK, Eli Lilly and managing board memberships in Proscion and Intomics. All authors affiliated with deCODE genetics are employees of deCODE genetics, a subsidiary of Amgen. The other authors declare no competing interests.